-
1
-
-
0029830418
-
Shanghai trial of nifedipine in the elderly (STONE)
-
Gong L et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237-1245.
-
(1996)
J Hypertens
, vol.14
, pp. 1237-1245
-
-
Gong, L.1
-
2
-
-
0025609078
-
Therapeutic considerations in the elderly hypertension: The role of calcium channel blockers
-
Black HR. Therapeutic considerations in the elderly hypertension: the role of calcium channel blockers. Am J Hypertens 1990; 3 (Suppl): 347S-354S.
-
(1990)
Am J Hypertens
, vol.3
, Issue.SUPPL.
-
-
Black, H.R.1
-
3
-
-
0028838189
-
The hypertension optimal treatment (HOT) study: 12-month data on blood pressure and tolerability. With special reference to age and gender
-
Hansson L, Zanchetti A. The hypertension optimal treatment (HOT) study: 12-month data on blood pressure and tolerability. With special reference to age and gender. Blood Press 1995; 4: 313-319.
-
(1995)
Blood Press
, vol.4
, pp. 313-319
-
-
Hansson, L.1
Zanchetti, A.2
-
4
-
-
9244236566
-
Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina
-
Dargie HJ, Ford I, Fox KM, on behalf of the TIBET study group. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J 1996; 17: 104-112.
-
(1996)
Eur Heart J
, vol.17
, pp. 104-112
-
-
Dargie, H.J.1
Ford, I.2
Fox, K.M.3
-
5
-
-
0029880167
-
Effects of metropolol versus verapamil in patients with stable angina pectoris: The Angina Prognosis Study in Stockholm (APSIS)
-
Rehnqvist N et al. Effects of metropolol versus verapamil in patients with stable angina pectoris: the Angina Prognosis Study in Stockholm (APSIS). Eur Heart J 1996; 17: 76-81.
-
(1996)
Eur Heart J
, vol.17
, pp. 76-81
-
-
Rehnqvist, N.1
-
6
-
-
2042455581
-
Calcium antagonists and mortality in patients with coronary artery disease: A cohort study of 11,575 patients
-
Braun S et al, on behalf of the Benzafibrate Infarction Prevention Study Participants. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol 1996; 28: 7-11.
-
(1996)
J Am Coll Cardiol
, vol.28
, pp. 7-11
-
-
Braun, S.1
-
7
-
-
0029132121
-
Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
-
Furberg CD, Psaty BM, Myers JV. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-1331.
-
(1995)
Circulation
, vol.92
, pp. 1326-1331
-
-
Furberg, C.D.1
Psaty, B.M.2
Myers, J.V.3
-
8
-
-
0029161079
-
The risk of myocardial infarction associated with antihypertensive drug therapies
-
Psaty BM et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620-625.
-
(1995)
JAMA
, vol.274
, pp. 620-625
-
-
Psaty, B.M.1
-
9
-
-
0031053865
-
Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
-
Alderman MH, Cohen H, Roqué R, Madhavan S. Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet 1997; 349: 594-598.
-
(1997)
Lancet
, vol.349
, pp. 594-598
-
-
Alderman, M.H.1
Cohen, H.2
Roqué, R.3
Madhavan, S.4
-
10
-
-
0030924337
-
Calcium channel blockers and cardiac mortality in the treatment of hypertension: A report from the department of health hypertension care computing project (DHCCP)
-
Bulpitt CJ et al. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the department of health hypertension care computing project (DHCCP). J Hum Hypertens 1997; 11: 205-211.
-
(1997)
J Hum Hypertens
, vol.11
, pp. 205-211
-
-
Bulpitt, C.J.1
-
11
-
-
0032485350
-
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
-
Estacio RO et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998; 338: 645-652.
-
(1998)
N Engl J Med
, vol.338
, pp. 645-652
-
-
Estacio, R.O.1
-
12
-
-
0030199181
-
Do calcium channel blockers increase the risk of cancer?
-
Pahor M et al. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996; 9: 695-699.
-
(1996)
Am J Hypertens
, vol.9
, pp. 695-699
-
-
Pahor, M.1
-
13
-
-
0030600342
-
Calcium-channel blockade and incidence of cancer in aged populations
-
Pahor M et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493-497.
-
(1996)
Lancet
, vol.348
, pp. 493-497
-
-
Pahor, M.1
-
14
-
-
0030826328
-
Use of calcium channel blockers and breast carcinoma risk in postmenopausal women
-
Fitzpatrick AL et al. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997; 80: 1438-1447.
-
(1997)
Cancer
, vol.80
, pp. 1438-1447
-
-
Fitzpatrick, A.L.1
-
15
-
-
0030965135
-
Cancer risk in users of calcium channel blockers
-
Olsen JH et al. Cancer risk in users of calcium channel blockers. Hypertension 1997; 29: 1091-1094.
-
(1997)
Hypertension
, vol.29
, pp. 1091-1094
-
-
Olsen, J.H.1
-
16
-
-
0032054681
-
Calcium channel blockers and the risk of cancer
-
Rosenberg L et al. Calcium channel blockers and the risk of cancer. JAMA 1998; 279: 1000-1004.
-
(1998)
JAMA
, vol.279
, pp. 1000-1004
-
-
Rosenberg, L.1
-
17
-
-
0030720782
-
A systematic review and meta-analysis of the incidence of cancer in randomized, controlled trials of verapamil
-
Dong EW et al. A systematic review and meta-analysis of the incidence of cancer in randomized, controlled trials of verapamil. Pharmacotherapy 1997; 17: 1210-1219.
-
(1997)
Pharmacotherapy
, vol.17
, pp. 1210-1219
-
-
Dong, E.W.1
-
18
-
-
0031877888
-
Treatment with calcium channel antagonists does not increase the risk of fatal or non-fatal cancer in an elderly mid-European population: Results from STEPHY II
-
Trenkwalder P, Hendricks P, Hense HW. Treatment with calcium channel antagonists does not increase the risk of fatal or non-fatal cancer in an elderly mid-European population: results from STEPHY II. J Hypertens 1998; 16: 1113-1116.
-
(1998)
J Hypertens
, vol.16
, pp. 1113-1116
-
-
Trenkwalder, P.1
Hendricks, P.2
Hense, H.W.3
-
19
-
-
0032212372
-
Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women. The Nurses' Health Study
-
Michels KB et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women. The Nurses' Health Study. Cancer 1998; 83: 2003-2007.
-
(1998)
Cancer
, vol.83
, pp. 2003-2007
-
-
Michels, K.B.1
-
20
-
-
0343487983
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
-
Staessen JA et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764.
-
(1997)
Lancet
, vol.350
, pp. 757-764
-
-
Staessen, J.A.1
-
21
-
-
0003177219
-
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
-
Ad Hoc Subcommittee of the Liaison Committee of the WHO and the International Society of Hypertension. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Hypertension Res 1997; 20: 61-73.
-
(1997)
Hypertension Res
, vol.20
, pp. 61-73
-
-
-
22
-
-
0032543880
-
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer
-
Lever AF et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer. Lancet 1998; 352: 179-184.
-
(1998)
Lancet
, vol.352
, pp. 179-184
-
-
Lever, A.F.1
-
23
-
-
0031050146
-
Calcium-channel blockers and risk of cancer
-
Jick H et al. Calcium-channel blockers and risk of cancer. Lancet 1997; 349: 525-528.
-
(1997)
Lancet
, vol.349
, pp. 525-528
-
-
Jick, H.1
-
24
-
-
0032543911
-
Interpretation in drug epidemiology
-
Olsen JH. Interpretation in drug epidemiology. Lancet 1998; 352: 162-163.
-
(1998)
Lancet
, vol.352
, pp. 162-163
-
-
Olsen, J.H.1
-
25
-
-
0022595497
-
The survival of treated hypertensive patients and their causes of death: A report from the DHCCP
-
Bulpitt CJ et al. The survival of treated hypertensive patients and their causes of death: a report from the DHCCP. J Hypertens 1986; 4: 93-99.
-
(1986)
J Hypertens
, vol.4
, pp. 93-99
-
-
Bulpitt, C.J.1
-
26
-
-
0028318733
-
Optimal blood pressure control in treated hypertensive patients: Report from the Department of Health Hypertension Care Computing Project (DHCCP)
-
Bulpitt CJ et al. Optimal blood pressure control in treated hypertensive patients: Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994; 90: 225-233.
-
(1994)
Circulation
, vol.90
, pp. 225-233
-
-
Bulpitt, C.J.1
-
27
-
-
0023705898
-
Treated blood pressure, rather than pretreatment, predicts survival in DHCCP
-
Bulpitt CJ et al. Treated blood pressure, rather than pretreatment, predicts survival in DHCCP. J Hypertens 1988; 6: 627-632.
-
(1988)
J Hypertens
, vol.6
, pp. 627-632
-
-
Bulpitt, C.J.1
-
28
-
-
0000336139
-
Regression models and life-tables
-
Cox DR. Regression models and life-tables. J R Stat Soc (A) 1972; 34: 187-220.
-
(1972)
J R Stat Soc (A)
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
29
-
-
0027255942
-
Apoptosis and disease
-
Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341: 1251-1254.
-
(1993)
Lancet
, vol.341
, pp. 1251-1254
-
-
Carson, D.A.1
Ribeiro, J.M.2
-
30
-
-
0028943734
-
Apoptosis in the pathogenesis and treatment of disease
-
Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
-
(1995)
Science
, vol.267
, pp. 1456-1462
-
-
Thompson, C.B.1
-
31
-
-
0028890119
-
Apoptosis and cancer: The failure of controls on cell death and cell survival
-
Martin SJ, Green DR. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 1995; 18: 137-153.
-
(1995)
Crit Rev Oncol Hematol
, vol.18
, pp. 137-153
-
-
Martin, S.J.1
Green, D.R.2
-
32
-
-
0026494066
-
Calcium signals and cancer
-
Whitfield JF. Calcium signals and cancer. Crit Rev Oncog 1992; 3: 55-90.
-
(1992)
Crit Rev Oncog
, vol.3
, pp. 55-90
-
-
Whitfield, J.F.1
-
33
-
-
9044229717
-
Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers
-
Kohn EC et al. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res 1996; 56: 569-573.
-
(1996)
Cancer Res
, vol.56
, pp. 569-573
-
-
Kohn, E.C.1
-
34
-
-
0031890560
-
Reversal of multidrug resistance by novel verapamil analogs in cancer cells
-
Choi SU et al. Reversal of multidrug resistance by novel verapamil analogs in cancer cells. Anti Cancer Drugs 1998; 9: 157-165.
-
(1998)
Anti Cancer Drugs
, vol.9
, pp. 157-165
-
-
Choi, S.U.1
-
35
-
-
0029556051
-
Dexverapamil to overcome epirubicin resistance in advanced breast cancer
-
Thurlimann B et al. Dexverapamil to overcome epirubicin resistance in advanced breast cancer. J Cancer Res Clin Oncol 1995; 121 (Suppl 3): R3-R6.
-
(1995)
J Cancer Res Clin Oncol
, vol.121
, Issue.SUPPL. 3
-
-
Thurlimann, B.1
-
36
-
-
0031881790
-
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer
-
Lehnert M et al. Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer. Br J Cancer 1998; 77: 1155-1163.
-
(1998)
Br J Cancer
, vol.77
, pp. 1155-1163
-
-
Lehnert, M.1
-
37
-
-
0029551148
-
Randomised trial of vindesine and etoposide +/- dexverapamil in advanced non-small cell lung cancer: First results
-
Gatzemeier U, Schneider A, von Pawel J. Randomised trial of vindesine and etoposide +/- dexverapamil in advanced non-small cell lung cancer: first results. J Cancer Res Clin Oncol 1995; 121 (Suppl 3): R17-R20.
-
(1995)
J Cancer Res Clin Oncol
, vol.121
, Issue.SUPPL. 3
-
-
Gatzemeier, U.1
Schneider, A.2
Von Pawel, J.3
-
38
-
-
0029553840
-
Modulation of multidrug resistance by dexverapamil in EPOCH-refractory lymphomas
-
Wilson WH, Bates SE, Fojo A, Chabner BA. Modulation of multidrug resistance by dexverapamil in EPOCH-refractory lymphomas. J Cancer Res Clin Oncol 1995; 121 (Suppl 3): R25-R29.
-
(1995)
J Cancer Res Clin Oncol
, vol.121
, Issue.SUPPL. 3
-
-
Wilson, W.H.1
Bates, S.E.2
Fojo, A.3
Chabner, B.A.4
-
39
-
-
0029551147
-
Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma
-
Scheithauer W et al. Phase I/II trial of dexverapamil, epirubicin and granulocyte/macrophage-colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. J Cancer Res Clin Oncol 1995; 121 (Suppl 3): R7-R10.
-
(1995)
J Cancer Res Clin Oncol
, vol.121
, Issue.SUPPL. 3
-
-
Scheithauer, W.1
-
40
-
-
0027533393
-
Cancer mortality and atenolol treatment
-
Fletcher AE et al. Cancer mortality and atenolol treatment. BMJ 1993; 306: 622-623.
-
(1993)
BMJ
, vol.306
, pp. 622-623
-
-
Fletcher, A.E.1
-
41
-
-
0031915212
-
Cancer risk of hypertensive patients taking calcium antagonists
-
Hole DJ et al. Cancer risk of hypertensive patients taking calcium antagonists. J Hypertens 1998; 16: 119-124.
-
(1998)
J Hypertens
, vol.16
, pp. 119-124
-
-
Hole, D.J.1
|